Compare EQH & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | SMTI |
|---|---|---|
| Founded | 1859 | 1982 |
| Country | United States | United States |
| Employees | 8000 | N/A |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 182.6M |
| IPO Year | N/A | 2008 |
| Metric | EQH | SMTI |
|---|---|---|
| Price | $38.01 | $18.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $60.80 | $41.00 |
| AVG Volume (30 Days) | ★ 2.8M | 53.4K |
| Earning Date | 04-28-2026 | 03-24-2026 |
| Dividend Yield | ★ 2.85% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | $43.41 | $20.66 |
| Revenue Next Year | $7.61 | $13.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $36.79 | $18.29 |
| 52 Week High | $56.61 | $35.70 |
| Indicator | EQH | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 40.41 |
| Support Level | $37.51 | $18.60 |
| Resistance Level | $54.74 | $21.14 |
| Average True Range (ATR) | 1.48 | 1.00 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 27.49 | 4.00 |
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.